Current indications for growth hormone therapy for children and adolescents.

The approval of rhGH therapy for short, non-GH-deficient children has validated the notion of GH sensitivity, which gives the opportunity to some children with significant short stature, but with normal stimulated GH test results, to benefit from rh GH therapy and perhaps attain an adult height within the normal range and appropriate for their mid-parental target height (genetic potential).